Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.450
-0.010 (-0.22%)
Apr 2, 2026, 9:57 AM EDT - Market open
Camp4 Therapeutics Revenue
In the year 2025, Camp4 Therapeutics had annual revenue of $3.50M with 436.50% growth. Camp4 Therapeutics had revenue of $348.00K in the quarter ending December 31, 2025, a decrease of -46.63%.
Revenue (ttm)
$3.50M
Revenue Growth
+436.50%
P/S Ratio
66.20
Revenue / Employee
$72,875
Employees
48
Market Cap
231.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.50M | 2.85M | 436.50% |
| Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAMP News
- 9 days ago - CAMP4 Appoints Michael MacLean to its Board of Directors - GlobeNewsWire
- 26 days ago - CAMP4 to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 weeks ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 3 months ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire